Related Experiment Video
Updated: Jul 15, 2025
04:07
Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
Published on: February 24, 2023
1.7K
Deciphering the Pathways to PARP Sensitivity in Pancreatic Cancer
Erica S Tsang1, Steven Gallinger2
1Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Summary
Maintenance olaparib in BRCA/PALB2-mutated pancreatic cancer patients showed that reversion mutations correlated with poorer outcomes. Further correlative studies are vital for understanding drug resistance and informing future clinical trials.
Area of Science:
- Oncology
- Genetics
- Pharmacology
Background:
- Pancreatic cancer with BRCA or PALB2 mutations presents treatment challenges.
- Maintenance olaparib is a therapeutic option for select patients.
- Understanding mechanisms of drug resistance is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the role of cell-free DNA (cfDNA) in predicting response to maintenance olaparib.
- To identify genetic alterations associated with treatment resistance in pancreatic cancer.
Main Methods:
- Analysis of paired cfDNA samples from patients with BRCA- or PALB2-mutated pancreatic cancer.
- Correlative study design to link genetic findings with clinical outcomes.
- Assessment of reversion mutations in cfDNA.
Main Results:
- Reversion mutations in cfDNA were significantly associated with worse clinical outcomes.
- The presence of specific cfDNA alterations may indicate impending treatment failure.
Conclusions:
- cfDNA analysis can reveal mechanisms of acquired resistance to olaparib.
- Identifying reversion mutations offers insights into therapeutic resistance.
- These findings support the need for ongoing correlative research in precision oncology.
Related Concept Videos
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
01:31The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
01:02Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K
02:37DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:38Nucleotide Excision Repair
3.5K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.5K